117 related articles for article (PubMed ID: 2581495)
1. Multiple transcriptional activation of cellular oncogenes in human head and neck solid tumours.
Spandidos DA; Lamothe A; Field JK
Anticancer Res; 1985; 5(2):221-4. PubMed ID: 2581495
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of oncogene expression in head and neck tumours.
Field JK; Lamothe A; Spandidos DA
Anticancer Res; 1986; 6(4):595-600. PubMed ID: 3019219
[TBL] [Abstract][Full Text] [Related]
3. [Oncogene expression in malignant head and neck neoplasia].
Sartoris A; Aluffi P; Montemagno A; Gerbaudo EV; Gariglio M; Cavallo GP
G Batteriol Virol Immunol; 1991; 84(1-12):25-30. PubMed ID: 1844916
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of head and neck squamous cell carcinoma using comparative genomic hybridisation identifies specific aberrations associated with laryngeal origin.
Patmore HS; Ashman JN; Stafford ND; Berrieman HK; MacDonald A; Greenman J; Cawkwell L
Cancer Lett; 2007 Dec; 258(1):55-62. PubMed ID: 17920192
[TBL] [Abstract][Full Text] [Related]
5. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell.
Takes RP; Baatenburg de Jong RJ; Schuuring E; Litvinov SV; Hermans J; Van Krieken JH
Anticancer Res; 1998; 18(6B):4793-800. PubMed ID: 9891559
[TBL] [Abstract][Full Text] [Related]
6. Expression of cancer testis antigens in head and neck squamous cell carcinomas.
Figueiredo DL; Mamede RC; Proto-Siqueira R; Neder L; Silva WA; Zago MA
Head Neck; 2006 Jul; 28(7):614-9. PubMed ID: 16475205
[TBL] [Abstract][Full Text] [Related]
7. Overexpression and amplification of c-myc and c-Ha-ras oncogenes in pleomorphic salivary adenoma.
Xue H; Situ ZQ; Wang CJ; Wu JZ
Chin Med J (Engl); 1993 Jan; 106(1):22-5. PubMed ID: 8389270
[TBL] [Abstract][Full Text] [Related]
8. Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Harvey ras oncogene.
Spandidos DA; Agnantis NJ
Anticancer Res; 1984; 4(4-5):269-72. PubMed ID: 6207764
[TBL] [Abstract][Full Text] [Related]
9. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
10. Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma.
Field JK; Yiagnisis M; Spandidos DA; Gosney JR; Papadimitriou K; Vaughan ED; Stell PM
Eur J Surg Oncol; 1992 Apr; 18(2):168-76. PubMed ID: 1582509
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiles in HPV-infected head and neck cancer.
Schlecht NF; Burk RD; Adrien L; Dunne A; Kawachi N; Sarta C; Chen Q; Brandwein-Gensler M; Prystowsky MB; Childs G; Smith RV; Belbin TJ
J Pathol; 2007 Nov; 213(3):283-93. PubMed ID: 17893858
[TBL] [Abstract][Full Text] [Related]
12. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis.
Shin DM; Kim J; Ro JY; Hittelman J; Roth JA; Hong WK; Hittelman WN
Cancer Res; 1994 Jan; 54(2):321-6. PubMed ID: 8275461
[TBL] [Abstract][Full Text] [Related]
13. Oncogenes: preliminary studies in head and neck cancer.
Friedman WH; Rosenblum B; Loewenstein P; Thornton H; Katsantonis G; Green M
Laryngoscope; 1983 Nov; 93(11 Pt 1):1441-4. PubMed ID: 6633116
[TBL] [Abstract][Full Text] [Related]
14. [Oncogenes in squamous epithelial cancers in the area of the head and neck].
Volling P; Jungehülsing M; Tesch H; Stennert E
Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):160-4. PubMed ID: 3386367
[TBL] [Abstract][Full Text] [Related]
15. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of p53 protein is common in premalignant head and neck lesions.
Pavelic ZP; Li YQ; Stambrook PJ; McDonald JS; Munck-Wikland E; Pavelic K; Dacic S; Danilovic Z; Pavelic L; Mugge RE
Anticancer Res; 1994; 14(5B):2259-66. PubMed ID: 7840533
[TBL] [Abstract][Full Text] [Related]
17. Variability of genetic alterations in different sites of head and neck cancer.
Rodrigo JP; Suárez C; González MV; Lazo PS; Ramos S; Coto E; Alvarez I; García LA; Martínez JA
Laryngoscope; 2001 Jul; 111(7):1297-301. PubMed ID: 11568558
[TBL] [Abstract][Full Text] [Related]
18. Activation of Stat-3 as one of the early events in tobacco chewing-mediated oral carcinogenesis.
Nagpal JK; Mishra R; Das BR
Cancer; 2002 May; 94(9):2393-400. PubMed ID: 12015764
[TBL] [Abstract][Full Text] [Related]
19. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review).
Field JK; Spandidos DA
Anticancer Res; 1990; 10(1):1-22. PubMed ID: 2185684
[TBL] [Abstract][Full Text] [Related]
20. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
